Anti-Mouse IL-2 [Clone JES6-5H4] – DyLight® 488
Anti-Mouse IL-2 [Clone JES6-5H4] – DyLight® 488
Product No.: I-1040
																		                  -                          -        				
          											-						        						-									
      |  Clone JES6-5H4 Target		 IL-2  Formats AvailableView All  Product Type Monoclonal Antibody  Alternate Names  TCGF, Lymphokine, T-Cell Growth Factor Isotype		 IgG2b Applications		 FC | 
																		                  -                          -        				
          											-						        						-									
      | Antibody DetailsProduct DetailsReactive Species		 Mouse Host Species		 Rat Immunogen Purified Recombinant Mouse IL-2 (>98%) Product Concentration		 0.2 mg/ml Formulation This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. Storage and Handling This DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze. Country of Origin		 USA Shipping Next Day 2-8°C Excitation Laser Blue Laser (493 nm) RRIDAB_2830372 Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.  DescriptionDescriptionSpecificity Clone JES6-5H4 recognizes an epitope on mouse IL-2. Background IL-2 is a 17.2 kD cytokine signaling protein that is the regulator of the proliferative and suppressive phases of the immune response, and stimulates growth and differentiation of B cells, NK cells, LAK cells, monocytes, and oligodendrocytes. It functions as a primary regulator of T cell homeostasis. Il-2 regulates the activities of white blood cells and plays a role in the immune system via “self” and “non-self” discrimination. IL-2 is a prime candidate in immunotherapeutics for both increasing T cell levels/function and for augmenting vaccine-elicited viral-specific T cell responses. IL-2 signal can be transduced via 3 different signaling pathways that include the JAK-STAT, PI3K/Akt/mTOR and MAPK/ERK pathways. Aldesleukin is a form of recombinant interleukin-2 for the treatment of cancers including malignant melanoma and renal cell cancer. Furthermore, there is additional therapeutic potential for IL-2 mAb use with transplants and autoimmune disease. PubMed NCBI Gene Bank ID UniProt.org Research Area		 Immunology . Other Molecules References & Citations1. Schachter, J. et al. (2009) Cytotherapy 11: 206 2. Sodora, DL. et al. (2009) Curr HIV Res. 7: 83 3. Alcocer-Varela, J. et al. (2009) Autoimmun Rev. 9(1):34-9. Technical ProtocolsCertificate of Analysis | 
Related Products
																		                  -                          -        				
          											-						        						-									
      | Prod No. | Description | 
|---|---|
| I-1088 | |
| I-1089 | |
| I-1100 | |
| I-1094 | |
| I-1093 | |
| I-1095 | |
| I-1096 | |
| I-1101 | 
Formats Available
																		                  -                          -        				
          											-						        						-									
      | Prod No. | Description | 
|---|---|
| I-1100 | |
| I-1094 | |
| I-1093 | |
| I-1095 | |
| I-1096 | |
| I-1039 | |
| I-1040 | |
| I-1101 | 
 Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.

 
	
		 
		

